Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bubs Australia Ltd. ( (AU:BUB) ) has issued an update.
Bubs Australia, a specialist in infant formula and organic baby food with a strong presence in Australian retail and key export markets, continues to position itself around clean nutrition for early childhood development. The company’s products span A2 beta-casein, grass-fed organic, and goat milk formulas, alongside a broader baby food range available domestically and in ten overseas markets.
The company will host a Strategy Update Day in Melbourne on 26 March 2026, where the CEO and executive team will outline Bubs’ 2030 strategy and provide deeper insight into its business and markets. A presentation, webcast, and post-event recording will be made available to investors, underscoring the company’s push to engage stakeholders and provide greater transparency on its long-term strategic direction.
The most recent analyst rating on (AU:BUB) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Bubs Australia Ltd. stock, see the AU:BUB Stock Forecast page.
More about Bubs Australia Ltd.
Bubs Australia Limited is an Australian infant nutrition company founded in 2006, focused on clean-label products for babies’ first 1,000 days of life. Its portfolio includes Bubs A2 Beta-Casein Protein, Bubs Organic Grass-fed, and easy-digest goat milk infant formulas, as well as an organic baby food range, sold through major supermarkets and pharmacies in Australia and exported to China, Southeast Asia, the Middle East, and the U.S.
Average Trading Volume: 845,072
Technical Sentiment Signal: Sell
Current Market Cap: A$102.8M
Find detailed analytics on BUB stock on TipRanks’ Stock Analysis page.